Previous studies have been suggesting a key role of COX-2 in carcinogenesis [12, 14] and its modulation has been associated with reduction of tumor incidence in experimental and clinical studies for distinct types of carcinomas [15–17]. The gene discussed is PTGS2; the disease is carcinoma.